Labs reject dramatic findings on cancer drug in Alzheimer's miceBy Julie Steenhuysen CHICAGO (Reuters) - U.S. scientists say a dramatic result last year suggesting that a cancer drug already approved by U.S. regulators could quickly clear out Alzheimer's plaques in mice was too good to be true. The study, published last year in the journal Science, showed the skin cancer drug bexarotene cut the amount of an Alzheimer's-linked protein called beta amyloid by half in three days. It also reversed Alzheimer's symptoms, restoring a sense of smell in treated mice and allowing them to resume nest building activities. ...
Source: Labs reject dramatic findings on cancer drug in Alzheimer's mice (http://news.yahoo.com/labs-reject-dramatic-findings-cancer-drug-alzheimers-mice-180505373.html)